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INTRODUe'l'ION

The 1945 Alltlb.nac of the Dapartment of Health of
the-state of Nebraska cont&.ins comparative statistics
for the principal and other causes of debth for the
first six months of a five �ear period, 1940 to 1944
inclusive (1).

When these statistics a re examined, it

is found that there were forty�six de�ths due to whoop
ing cough in the St&te during this time.

During the

same period, there �ere recorded twenty de&ths due
to diphtheria ., twenty-thr-ee due . t o scarle t fever,
three due to typhoid fever, and no deaths due to sm�ll. p-ox.

We may conclude ., therefore, ths."t there a.re today

approxllll6.tely as many deaths due to pertussis in our
own state as 4eaths due to these other four diseases
combined.
Wb,oop1ng cough is a dise&se of which it may be
said that the multiplicity of remedies is an index of
therapeutie failure.

In 1928, Sauer and Hambrecht ("2)

expressed the observation which still exists today, that
"whooping cough causes more deaths than do most -of· the
other communic&,bl� diseases."

In

1944, Sauer confirmed

(3) thb.t whoopin6 co� bas lons been known to have a

high mortality in 1nf�ney.

- l ...

It has a case fatality of

about 25 per cent in inf'e.nts under one year of &.ge
and about l-0 per cent in infants in the second
of life.

In the United Stb.tes it tt..kes over

lives annually.
It is my purpose in this paper to bring forth
the steps �hich,have been passed in gath�ring
on the immunologic aspects of whooping cough ., and to
attempt

b.ll

evaluation of methods wh�ch have been used

in the µrotection of children against the•disease.
THE DEVELOPMENT OF PERTUSSIS VACCINE
Ballou, in 1588, described:a diseMse �haracter'ized by spasms of coughing {4).

This apparently is the

first description o1 whooping cough.

There was little

adv&nce made in the study of this disease during the
f'ollowing three centuries.

Durlng th;s interv&.1,
a

se&rch·w&.s be�ng made for remedies to alleviate the
d�se&se �nd scores of medicines were tried.
Thomson (5) wrote in .1831, "I have onky further
to notice th&t hooping co.ugh is said to be cut short,
in its progress, by v&cciru..tion (smallpox) on the
third week after the commencement of the hoop.
method of tre&.tment

Wb.S

This

first suggested in Germany·,
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and its efficacy is said to have been confirmed in
America.."

The procedure was upheld by Chevalier (6),

and. by Adam (i).

These two workers, however, pointed

out that it is iDllu&terial in what period of the cough
the virus is given, the influence is the same.

It is

inte�est1ng to note that these ebrlier workers consider
ect delaying v�ccin�tion until it couid be utilized in
the therapy ol whooping eougn.
In 1860, Carter, in London where the vaccination
trehtment wa.s being upheld, expressed the feeling of
the medical protession at th-1:1.t time (8), "Perhaps
is no disease for whieh so many specificities and
inf al.Lible nostr,.1ms are promulgated with confidence-,
or so f.ew a.ctus.l remedies known."
The use of tr�e s111ti.llpo� v·accination treatment for
pertussis was referred to by McElroy in 1870 as f6llows
(9), "Before &ny of us began to practice, or even to
study our professions, it was lauded as a. specific,
tried in a Pbris hospital, fbiled, and was dropped
out 01 the medichl·liter&ture; for vaccination is
not even mentioned in the most recent works on
general prbctice, or the special mana�ement of diseases
of childhood, as a proper remedial �easur6 in the
professional management of· pertussis."
The scientific work on the disease had its
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besinnlng in 1909 when Bordet {10) pubiished the
res·:1lts ot e·ert1..in rtse&.rch which he unde·rtook in
collf;lboration with Gengou.

They discovered and

described the micro-org�nism of whooping cough,
the Bordet-Gengou bacillus (Hemophilus pertussis),
bnd cultivated it upon.media which they devised.

No

other specific micro-organism has been designated as
the cause ol whooping cough since that time.

Their

work was the basis to which has been added a vast
amount of knowledge of the serological aspects of
pertussis, through sustt41ned sc1ent11 ic research.
Since the .original work of Bordet 1...nd Gengo_u
f'ur-nishes the foundb.tion of all scientific investi
gation, an accurate description of their findings is
best stated in the original.
&.

Bordet wrote, "!·mentioned

little while ago thli-t the microbe of whooping cough

prefers a blood medium, but that it can be accustomed
to ltve on ordinary a.gar.

Thus we get two distinct

v�rieties, which we m.y eall the blood' germ and the
ag&r germ. In rel&.tion to serum reaction, .these tw_o

v�rieties behave quite differently.
"If an ani�l be immunized against the blood germ,
and, on the other hand, agc:inst the agar germ, serums
by no me1.1.ns identical are obt&.ined.

we may conchide,

therefore, that the microbe of whooping cough, when
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grown on a common agar loses the property of re�ct1ng
with an agglutinin capable of influencing the same germ
when grown on a medium rich in blood. FUrther, this
property is regained when ·agar germ is replanted in
blood medium."
He rurther describes the presence of a remarkably
irritant toxin which causes the lesions of the cellular
lining of the bronchi. He states that this explains
why the whooping ceases to be a featur e of the clinical
picture during the period immediately preceding con
valescence, when the germ has become very rare in �he
exudate. The child has now succeeded in getting rid of
the virulent organisms, but repair of the damage caused
by the poison takes place but slowly.
He believes for this same reason, serwn therapy
has failed to give the res�lts which were hoped for.
The diagnosis of whooping cough 1s nearly always a.elay
ed until the e.ppearwice of the cru..racteriatic cough; QY
this time the infection has obtained a firm hold and the
toxin has alre&dy pro.duced its necrotic effect. He
concludes by stating, "I think that the vaccination by
killed cultures should be much more useful."
Thou gh the Bordet-Gengou bacillus was generally
regarded as the most import&nt etio1og1c�l factor in
whooping cough, still the medical profession as a whole
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was not entirely ready to ·accept the fact that it
the proven specific cause--or the only organism
inv-0lved.

Thi� was aue mostly to the fact that not

only the Bordet-Qengou ba.ci}.lus but

&s·

Will.lams ( 11)

stated, "many organisms of the hemoglobinophilic group
of bacilli b.re also found in cases observed.tr-

The

re$�lt was that a variety of stock preparations of
v�ccines was produced.

some consisted 01· p\U'e cultures

of the Bordet-Gengou bacillus; but others were s: com
bin&.tion of Bordet-Gengou� staphylococci, m1crococc1,
catt:1rrhalis and influenz.a bacilli.
The early workers with pertussis �accine and
combinations including the Bordet-Gengou b�cillus were
interested in the therkpy

of the disease.

Their appli-

cation of the vaccine was always after the diagnosis had
been made, hopin� tp alleviate the symptoms and shorten
the course ·o1 the disease.

Hartshorn and Moeller in

l914 reviewed the literature on the use of pertussis
vaccine in the therapy of pertussis (12).

They found

th�t there had been reported in the literature up to
that time 1,445 cases wherein pertussis vaccine and
its combinations h&d been used and the res-q-lts observad.
These authors considered the use of a. combined
vaccine a.s hardly a log!cal tre�tment; but also recog
nized that the need of' ·a. successful treatment ror pertussis
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was unquestion�bly so great that no therapeutic
measure should be disregar ded until after a thorough
trial.

The Vb.CCines up to this time were used in a

dosage of" �_, 000,000 to 200,000,000 organisms given
every three to five days, depending Upon the age of
the patient and the severity of the symptoms.

After

a study- of the 1,445 cases, they noted that· there was
a st�iking laeir of negative reports; the dosage used
has apparently been _too small; the earlier tbe• treatment
is c,iven the oetter the results; the relative value of'
the combined vaccine as compared to the single culture
vaccine is unde�ermined; the improvement in a few csses
being immediate and striking, it seems fair to suggest,
b�t not to reeommena, its use.
It seemed to be the ch�racteristic conclusion

or alt the investi�ators that larger doses or organ
isms �ho�ld be given.

Ladd (13), who had been using

dosages of-2v,Ov0,000 organisms, recommended tn1ns
40,000,000.

Graham (14), who fo�d seven�y-one per

cent of his p&.tients benefited with dosages of 49,0UO,OOO,
expressed the probability of better results with
dosages up to 100,000,000 o�gE:.nisms.

Bamberger {15)

recommended doses of 500 ,000-,000 organisms, and also
expressed the need for more frequent inJections.
Pertussis bacillus vaccine was admitted to New
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and Non-Off'1c1s.l Remedies in 1914 on the basis of what
appe�red to be acceptible clinical evidence (16).
In 1915, the following statement appeared in New and
Non-Of1'1c1Ei.l ·Remedies under the heading of Pertussis
bacillus vaccine (17), "The evidence indicates that
it is of value both for prevention &nd treatment,
although eminent a.uthori.ties st1::-. te the-. t the results
have not been very satisf
_ s.ctory. n

In 1916, Hoag {18), using a polyvalent serum

conta1nine, several strains of pertussis organisms
and standardized with one billion organisms per cc.,
recorded very good results.

He gave injections to

patients after exposure but beiore any symptoms develop·
ed.

These patients received three injeetions within

one week, of 0.5, 1.0, hnd 2.0 cc. of the pertussis
vaccine. Of seventeen exposed cases receiving
the vacd.ine,
_
not one developed the •disease.

He also recommend�d the

use 01' the v&.ccine in any sta.6e of the disease, even in

well adv&nced paroxysmal stE1.ge.

He ste.ted in this

resvect,. "Any remedy which will shorten the paroxysm&l
stage of· pertussis one week, or longer even, should be
hai�ed as a boon, for it is during the latter weeks,
�hen the patient is 1ncre&singly weakened by stress,
deficient nutrition and want of sleep, ths.t the great�
est possibilities of complications and sequelae arise ••
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• ••• one mothe.r· lost two children within three days with
pneumonia complic�ted by meningitis, where no vaccine
was used, while a. four month old inf'ant in the Sb.me
J a.miJ,.y promptly recovered where the v·accine was begun
about the tenth day �f the disease."
Bloom (19) wrote of very good results using-a
"mixed" vaccine which he believed.
Bordet-G&n6ou blicillus vaccine.

be, t t.er
" -. tha.n a s_imple �
t]sing one to four

bill.ion organisms in patients after exposure 'but before

symptoms developed, he found institutional whooping
coue,h reduced from forty to seven per cent.

Used in

a aimilb.l' total dosage fo1· therapy, he found
- lessened.
cour•st; shortened &nd its severity

Simil-s.r

result-a w1 th the use of a "mixed" vaccine used in
therapy. of _pertussis was reported by Cheney (-�).
Luttin�er (21) seemingly obtained falrJ__y good
resi.llts -•ith a specific H. pe1·tussis_ vt1eeine used both
in prophylq1s alter exposur� and in therapy.

He con

cludes by st&ting, "The results obtained bt the whoop
illt> co�gh Clinic and by over 180 pr1v�te physicians arrl:l
heb.lth of't:icers would warrant the routine administrEi.tion
of pertussis vaccine for both cur�tive and prophylactte
purposes."

However, he thre
- w doubt upon the efficacy

of a specific H. pertussis vaccine by showing tht1.t the
resu.lts of an inf.1.uenza V8.Ccine coll&.ted by one of his
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coworkers was equally as �ood.

His expression was

it w&s not out of the realm of possibility that any
protein may help to incre�se the general resistance
,:,

of the body.

Von Sho.Ll.Y, (22), reporting for the Bure&u
Labo1·atories of' the New York City Health Department,
. warned &g�inst undue optimism over· the use of'
pertussis vaccine in therapy.

He pointed out that

statistics to dhte had been too few &nd m&ny times
b&.sed on •impressions".

statistics, to be of any

valu.e, rnust be drawn from sevt.ral thousand ca.ses.

The

shortest courst of whoopin8 cough in their experimentation
WbS run in non-vacc���ted controls and in those receiv
ing inert, milk-colored water.
In 1;;117, Huenekens (23), pointed out that the
evidence on the results of vaccines made thus fe.r
had becri ohiefly c..Linical, a.nd t
_ hht if vaccines are
of v&.lue it would be ru:..tural to expeet that-after their
administration, specific antibodies woild be present in
the olood.

The agglutination test in pertussis had been

tr1ea by many workers but h�d been f&r from satisfact
ory.

The complement-fixation rea.ct�on, however, had

been more successful, but had been used mostly in
providinb a diagnosis of whooping cough.
In 1�25, Madsen (24), by using the colllj_)lement-
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fixation test, showed that no rE;action is observed in
the

oe 6inr.ing

of the ehtl:i.rrha.l stage, but that after

the first week the reaction increases g�du&lly and
re..,ches 1ts maximum the fifth to seventh week, after
which it slowly be�ins to decline-- the reaction last
ing for m&ny months to a year.

He also found th�t it is

possible to ca.use �n increase in the amount of the
complement-fixing. substance in persons vaccinated with
whoopin6 cou6h v&ccine--a ma ximum being reached eight

days after the la.st injection, followed by a fall.in
the curve.

If the patient already had whooping cough

when the v�ccination w�s commtnced, only a small in
cr·ea.se in the quantity of the antibody was observed.
He relates also his experience in the Faroe Island
epidemic of whooping cou�.

On this isolated island, a.

whoopin0 cough epidemic was seen every four to rive

ye&rs, w.tien a. new crop ot susceptil)les beca me avail•
able.

The Vta.ccine used was of Bordet-Gengou bacilli

grown on forty-eight hour blood s.ga.r.

The concentration

v.as ten bil.lion organisms per cc., and injections were
e>iven three times, s1.1bcl.1tb.neously or· intrEi-muscularly,
with a. four db.y interv&.l l0.5, 0.7, and 1.0 cc.).

He

found the Vb.Cc1ne most effective when given about one
.

.

week before the disease bre&.ks out.

The total material

from this epidemic consis.t ed _?f 2,094 vaccinated with

five de�ths, &nd 627 non-vaccinated with eighteen
- 11 -

deaths; morthlity was twelve times as great in the
non-vaccin�ted, and the attacks much more severe •
Doubt existed in his mind, however, as to the exact
speci.t icity of tht:1 whooping cough vaccine and wondered
whether the effect mie)lt not be due merely to a
protein effect of the injected baeilli.
Sauer and Hambrecht (2J stressed that the
reports on the Vk�ue of H. pertussis vacclne as a
therapeutic agent were highly c::mtradictory_ and of
little scientific value becallse they laeked proper
control material.

Since its introduction, many author

ities had abandoned it or questioned its worth as a
therapeutic agent.

They emphasized the fact th&t the

object of injections 1s to hasten n�tural antibody
production, but that all vaccine administered is given:
too 11:1.te .tor sufi1c1ent antibody production or atra
time when the body is already overwhelmed with the
living baci�li and their products.

After givin� three

doses at threE- day intervals, they found that the
dise�se w&.s not prevented in def1nit-ely exposed sus
ceptible children, or that V&.ccine therapy had little
11 any influence on the course of the dise&.se'in one
hundred p�tients.
In the Reports of the Council on Pharmacy and
Chemistry of the Americtm Medical Association for 1�31,
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w~ 1ind the following (25J, "As a preventative, B.
pertussis vacc~nes seem to h&ve aosolutely no influence,
&nd ·after the disease is thoroughly established even
freshly prepared vaccines seem useless •••• In view of
the fact that in fifteen years of extensive use no
acceptable confirmatory evidence for the value of B.
pertussis VbCCines has become available, the Council
voted to co n iirm its decision to omit from New and Non011icial Remedies the accepted prod~cts ••.••.• "
The most significant scientific advancement in

•

the knowled~e oi B. pertussis serolo~y s i nce Bordet's
discovery of the organism in 190~ was made by Leslie
and Gardner in 1931.

They found (26) that Remophilus

pertussis, after isolation from the human subject, t.ends
to p1;;.ss throllt!)h a series of antigenically distinct
phases, of which the first two phases are toxic to guinea
pigs, whereas the last two a.re relatively harmless.
The _ former probably correspond to the smooth, the latter
to the rOi.le,h .;>base of other bacteria.

They stt1.te, "Our

analysis o1 thirty-two strains of H. pertussis by
&g 6 lutin1;;..tion, &.bso1,ption of ag1:,lutinins, and tests of
a 6 6lutinogenic properties have proved that they all f~ll
into one or other of iour well-markea aggllltirn, tive groups,.
hich we call Phases 1, II, III, and IV."

Experiments

on gi.line~ ~igs produced some evidence that the toxic
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Phase I is the Oest and perhaps the only antigen for
the p roduction of active immunity in guineu pigs.
It at once became evident that the best results
wlth B. pertus sis vaccines would likely be had if only
the organisms in ~has 6 I were used.

Sauer t27J reported

Vbry bood results by using a vacci n e made from recently
isol&ted, hemolytic strains, in a concentration of ten
billion organisms per cc., and

6

ivin6 from seven to

ei 6 ht cc. for prophylactic pur p oses.

Re reported 135

exposures without any child contr ~ cting whoo p ing cough.
Macdonald and Macdonald (28), by using the method of
Sauer, reporte,d active immunity by prophylactic
injections. Madsen (29) pointed out th&t his good
results with the prophylactic use of B. pertussis
v a ccine in the Faroe Islands was probably due to the
fact that 2.2 billion organisms of young strains were
given, and at a time so that the titer of the antibodies
p~oduced DY the vaccine was at its highe st at the
time ·of the epidemic.
Krue6er (30) described a technic for obtaining an
antiben from the H. pertussis. He stressed the importance
of getting at the bacterial "endoproducts" without
den&.turation of the pr·oteins. The p rocess included a
mechanical disruption of the cell membrane and ultrafiltration of the endocellular products. Munns and
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Aldrich (31), using this H. p ertussis endoantigen of
Krueger in a total dosage of

11

endoproducts" equal to

1.5 billion organisms for both treatment and prophylaxis
after exposure, reported 55.5 per cent protection after
exposure and 75.2 per cent having moderate or mild
attacks after receiving the antigen. They recommended
giving larger doses. Favorable results with this
endoantigen were reported by Frawley, stallings, and
Nichols (32) , ·. and by Frawley {33). The latter is signific8nt in that a control group showed a marked contrast
to the group receiving the antigen ·which had been given
for active imnmnization at the onset of a whooping
cou1::,h epidemic.
Sauer (34) wrot6 an extensive revie1 of the facts
known and unknown about the p er tussis vaccines and
immun ity. The great number of variables in judging
the efficacy of B. pertussis vaccine were brought ;nto
the light. The import~nce of recognizing these variables
in re~ching conclusions was stressed. He pointed out
that when whoopin 6 cough occurs during the first few
yebrs of life, its course is often influence~ by age,
previous health, nutritional st6te, stbbility of the
nervous system, h ygienic care, climat e and season. In
the vaccinbt ed bnd non-vaccinated the duration and
severity often var) gre~tly . He emphasized that
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appreciably more than twenty-five per cent of vaccinated
children .s hould escape the disease when they are
definitely exposed to infection, because the communicability index for pertussis is about seventy-five per
cent. He believed the best controls for experiments were
to be had by usin~ non-immune (non-vaccinated) siblings,
since exposure to infection is more likely to be early,
intimate, rep e ated and prolonged when it occurs in the
family.
Though he set the time required for the child to
obtain immunity at three months after the 1·ast injection
of vaccine, he speculated that the immunity response
might be hastened oy injections at shorter intervb.ls
(i.e., the ei ght cc. within a week). A lymphocytosis
was found, quite like that of pertussis, a month after
vaccine injections. He fo ·1.md that about ten per cent oi'
the childr en injected with a total of eight cc. of the
approved commercial vaccine contracted pertussis when
subsequently exposed to infection. He concluded,
11

Bacillus pertussis vaccine, like typhoid vaccine, is

an immunizing agent--not a curative agent." Bumbalo (.:i-5) , .
in a series of 447 cases, concluded that the use of
pertussis vaccine in the therapy of pertussis was of
little value.
Shorr (36) found that the intra.cutaneous method af
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administration of pertussis vaccine, although associated with rather marked local reactions, gave
agglutinin response comparable in titer with that
f'ound in children receiving from seven to eight times
as much vaccine subcutaneously or intramuscularly.
Mishulow {37) obtained similar differences in agglutinin titer a f ter comparing these methods. She found also
that the agglutinin response in vaccinated children was,
on the whole, proportional to the dosage given. BY
compb.rison of titer curves, it was found that the
ag 6 lutinin response in pertussis differed markedly
from that of the vaccinated children, in the length of
time at which the maximum was attained and in the height
of the curve. A similar rapid drop in ag 6 lutinin titer
WcJ.S

found to follow closely both the disease itself

and activ~ immunizat ion.
Gold ( 38) wrote, "The clinical picture of pert 1.1ssis
may be divided into two components: first, the paroxysmal
stage, very likely due to sensitization of the mucous
membrane of the upper respiratory tract by H. pertussis
or its products; the second, the stage of low gr bde
inflammation, re~resented by persistent hacking cough,
and due to secondary bacterial invasion of the respiratory
tree.

It occured to Roos {Per·sonal Communication) that
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control of the p&roxysmel stabe could be best
&ccomplished throQgh locul sensitization by means
of the n&sal administrbtion of a suitable antigen
so.Lution.

11

Roos, in the lators.tories of Sharp and

Dahme, pr·t:pared an &nti 6 en which Gold used, five to
ten drops given daLJ.y intranasally, in twenty-eight
c""ses of whoopin 0 cough.

Of these, seventeen responded

with excel.Lent results und seven with good results, or
a total of ei 6 hty-five per cent satisfactory control of
toe severe ?aroxysms .

Slesinger (39) re 9orted only

seventy-five pbr cent s&tisfbctory control of paroxysms
with this intran&sal anti~en.

Lor- 6 and Bliss (40}

sho~ed th~t the introduction of pertussis antigen
into the nasal passages of raobits and human beings
caused the development of complement-fixing antibodies
in their sera.

They re&lized, however, that the sig-

nificance of these complement-fixing bntibodies was
not y~t known in respect to pertussis immunity, and
th~t this may have been an antibody response which
is non-essential in the &ctual immunity to the disease.
Miller and Singer-Brooks {41) attacked the good
resc1lts obtblned with Krueger's "endoantigen 1r or
per·tussis

u.

,lj.

A. (UndE:natured Bacterial Antigen).

Their expE-riments failed to Si.lbstantiate the confirmatory
findings which had be~n reported previously by Frawley,
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Stailin 6 s and Nicho ls, Munns and Aldrich, und by
Fr&wley.

They believed that hos p italization was nec-

essary for observti.tion and critical judgment on the
res..ilts o1 su.ch therapy, since the normal course of
per· tass is is so vu.riatle.

Thompson ( 42) , i n London,

published his findln 6 s whicb also were contrary to
the fkVOrb.ble reports on the use of U. B. A ..
Toomey (43), reco~nizi ng thb.t the isolation of
the H, pertussis in Phase I is mo s t difficult after
the catarrhal stage is ~assed, reasone d that the whoopin~ sta 0 e 1s due to the sticky mucoid exudate which is
cou 6 hed

UJ

with each paroxysm .

This st icky material

is not p roduced by Pha se I orga nisms but by lower Phase
organisms, as can De proved by in vitro experiments.
He reasoned thc.t since a cur·e for the clinic&l disease
is br·ou 6 ht aI)out when the pertussis mucoid mi:,.teri &l
is counteracted or di s )osed of, actu.al att&cks of the
disease mi 6 ht be shortened by injecti o ns of this
specific factor.

He r·eporte a. shortened attacks and a

decrease in nJmber o1 p~roxysms, with some cases where~
in the whoop was aborted entirel y .
wnen injections were

6

Results were best

iven immediately a f ter ·exp osure.

These experiments l&cked control material.
In 1~33, Mil~er showed (44) th&t mice could be
re~~l~rly killed by meni n 6 ococci suspended.in hog's

0

&stric mucin.

Silvtrthorne (45) applied the method

of injectin~ strains of H. J ertussis, suspended in
0

astric mucin, intraperitoneally into mice.

He offered

this us a metLod of tE-sting the protective va1.ue of'
pertussis v &cc ine previously administered to the mice.
Ninety to one hundred per cent of unv&ccin~ted mice
died, while one hundred per cen t of previously
vaccin~ted mice survived.

Previously, Kendrick, Gibbs,

and Sprick (46) had sugsested the use of the opsonocytopha6ic test as a crit&rion for studyin 6 imrnun6
respon;.,e in per·tussis, . and for a comparative study
of cul tu.r·es and v&ccines.
In 1~39, Sint:,er-Brooks 1·e ported ( 47) on a controlled stud~ of the use of Phase I H. pertussis
vaccine &nd of U. B. A. in expo 8 ed children.

Of 272

children given injections of the Vbccine, forty-two
werb exposed and seven (16.6 per cent) contracted whoopin6 cough.
of the

u.

Of ninety-five children given injections
B. A.,thirty fo~r were exposed and twenty-eight

( 8~ .3 per cent) contracted the disea~e .

Of 256 control

chil dr~ n, seventy-one were exposed and sixty-two (87 .2
per cent) contracted the disease.

u.

Thus it appears that

b. A. confers pr~cticblly no protection agbinst

per·tussis.
Me~n~h ile, clinical results with H. pertussis
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vaccin.E: injections f or prophyl&ctic immunization were
bein 6 re ~ orted.

Doull, Shibley, and McClelland (48)

were not very e n thusi&stic over their results.

How-

ever, Sieeel and Goldberger (49) re ported good results
in a Children's Tuberculosis Hospital.

The procedure

of prophyl~ctic immunization was upheld by Silverthorne
1:i.n d Fr i:,. ser (50), SilvertLorne (51), Kendrick and Elderin6 (52), and. Miller &nd F&ber (53).

Lewis, et al

(54) f1::1iled to obtc;,in the desired results until the
tot&l dosa e was raised to 80 billion organisms.

They

f oinci. that i n their institutional study, a total dosage
of 130 oilLion org&nisms was much more E: ffectiv e than
80 bil.Lion, and recommended the 11:tr ger· dosage, comparin6 household ex ~osures to institutional exposures.
In 1~39, Sauer (55) recommended a new concentration
of autho rized H. pertussis vaccine wher·e in one cubic
centimeter· wo 1ld cont&in twenty billion orgunisms.

Th.e

r·e co mmended tot&l dosage was five cc. for children (1. 0 ,
~ .O, and 2.0 cc. at weekly interv ~ ls) under two years
of ae;e, and six cc. for those over two years of age (1.0,
2.J, ~nd 3.0 cc. at weekly intervals).

He pointed out

that t h e di11erence of o p inion on the immuniz'ing virtue
01

vaccine is augmented by the various ways in which

vaccines h&vc been made--from old stock strains or
recently isol &ted cultures; some mediums contain blood,
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other·s uo not; some Vl:iCCines are "washed", others
are not "washed".
In l<.:140, Faber und Miller summ&rized the results
oi the seven major studies that hl:id been mbde on the

use of pe rtussis vaccine in prophylactic immunization
(b6}.

Six of the studies were f'&vorable; one study,

th&.t of Doull and his accoci a tes, had not been favorable.
They pointt::d o ,lt that though the success of immunization
a~ainst pertussis with the dosages generally used is
not quite compar&.ble to thl:i t of immuniz,a tion a.gains t
di9htheria l::tnd sml::tll pox in completeness and per cent
of subjects protected, still seventy-eight per cent
protection attaint d with good pertussis VbCCine (th e
vaccine of Do:.111 was ineffective) is h igh enout>h to justify ~eneral adoption of the method and its inclusion
in the routine progr&.m of immuniz&.tion for infants and
you.n6 children.
Sha~ (57) pointed out that it is a mistake to
insist upon or expecl "solid" immunity.

In order for

a v&ccine to prove it s value, it is necess&ry only to
demor:str.,.te that it incre c.ses the resistanC'es to attacks;
vhen this is l:i~reed up on, modification of method and
exte nsion oi application mi;;ly be expected to improve
the resu.lts.

It is now ~ossible to be certain that

pertussis immunization with adequate doses of the Sauer
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ty~~ VbCcine does increbse the resistance of the small
child to attack.

The fi~ures repoI'ted to di:::te are

signific&nt and could not .ricr.uI' by chance.
In ld43, Jacobs, in a district of New York City ,
conducted. a cc:1ref'ully controlled experiment in v.:hich
2l38 inf&nts and chiJ.dren, ranging in age from one
month to ten yea.r·s of ae:;e, were followed d 1ring their
1

entire course of whooping coubh (58).

One hundred and

elbht of these patients served as controls &nd received
no specii ic t.t1erapy, and. the duration and severity of
their cases was used as a stand brd of comp arison.
P&tiE:- nts treate d with injections of pertussis antigen,
pertussis vaccine, ana a mixture ot equbl parts of both,
all showed definite im;J rovement in the course of the
dise~se.

However, patients given injections of triple

typhoid vi....ccine showed similar improvement, indicatinb
th&t t he effect of injection ther apy was essentialJ.y
(.;.Ue to non-s_t,)ecific stimulation of antibodies resulting
from forelgn protein injection.

Turnbull (59) obs e rv e-a.

similar results when injections of alum-precipitated
dipbther·ia toxoid wer·e gi ven.
ArlOtrH::;r group of J&.cob' s P"'- tients were given
injections of adren&.l cor·tex extract dur in 6 the severest
E;; L) idemic seas on .

The severity and dur·a.tion of whooping

cou6h in these patients

-
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mi:l.rkedl.y d imis hed.

Thou 5 h

the action here is considered to be non-specific and
the mbchanism unknown, Jacobs speculbted th&t it mi~ht
due to the restoration of the normal electrolyte
balance, thus permitting more r&pid &nd complete anti body formation .

It seems possible that iurther inves-

tig~tion und experiment~tion with a combination of
pertussis vaccine and &drenul cortex extre.ct in prophylaxis mi 6 ht prove to be benef'ici1:,.l to infants &.nd
small children.

SUMMARY

second attacks of whooping cough have been r6ported ~ut are rure.
&

Wher6 a b a ct6rial infection confers

lifelong immunity, we wou.Ld expect to obtain good

res~lts from prophylactic inoculations.

Vaccine therapy

in whoopine:, co •.1gh has h&d its ups and downs since it
was introduced oy Bordet in 1~09, but the uses of vaccine
has steadily gained favor as a prophylactic.
The use of pertussis vaccines might well be
divided into two chases in history.

Phase One might

be descrL0ed as the period before 1~3U, when 'most of
the vaccines were stock vaccines made from old l&bor~tory strains of H. p ertussis, rough from cultivation
on laboratory media.

Phase Two could di,_te from the
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publication by Leslie and Gardner i ~ 193 1, describing
the smooth to rougri tra.nsformation or variation which
take s plac e wh en strains of H. pertussis &re groVJn
f or long ~erioa s on laboratory me d ia.

It is n ow

general.Ly &.bre~d thb t pertussis vaccine should Le
mb.o.e on.Ly from strai11s of H. p ertussis which are in
Pha.se I.
The divergent results obta i ned in studies on the
prophylactic efficacy of pertussis vaccine are to De
explainea largely on the bbsis of the t yp e of organism
used i n t h e p reparatio n of t h e vaccine and the met h od
01

its p reparation, b.nd, to

&

lesser extent, on t h e

basis o1 dosage, interval b b tween injections, age of
the s bject immunized, and other factors.

There is,

in my o~ inion, to d&.te no laboratory or clinical
evidence which proves that any a nti~e n m&de of parts
or ~ roducts of the H. pertussis orgtinism is a more
effective imrnuni z.ing agent t han the v;hol e organism
it s elf .

Problems o1 dosage, interval betwee n doses,

a.be of pa tient immuni z e d , and other undecided and
aeb at ab ..1.e question s &re on l y to be definitely ans wered
in i utu.re ye &.rs.
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AGE. FOR IM.lUNIZATION

According to the recent mortality records, the
mujorlty of debths from pertussis occur in infants.
Between 1~3b bnd 1~40 inclusive, about 67 per cent
oi the 10,730 deaths from whoo p inb coubh rep orted
in the United states occured durin 0 the first year
of life, and 47 per cent of these deaths were in
infants under seven months of age (60) .

The

exce~tionally high mortality which pert~ssis exacts
..

in the first year of life has caused investigations
into the possibility of incre!:ising resistance of the
youn 6 infants to the disease by actively immunizing
them shor·tly a f ter birth.
The vrocedure has ·o een objected to chiefly beca..ise
of the belief that these younger infants l&.ck the
abi.Lity to develop active immunity.

However, very

little 1:;..cti.1al study has been done to establish the
earliest age t:.t which immunity to pertussis can be
acq_'-J.ired..

It h1:,.s been generally accepted that the

second hali-year of life, about seven months, is the
optimum a 6 e for immunization.

Unfortunately, halt of

the mortality of pertussis has materialized before
this abe is reached.

-
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~auer (ol) pointed out that althou 6 h some infants
&t three months of

&6 e

pos5ess the power to elaborate

the s~eci1ic antibody from hypodermically injected
H. pertussis vaccine, othe rs seem to lack this power.
He f ound tha.t pertussis occured seven times more
frequently among, childr·en inoculated before the third
month of life than amon 5 those inoculs.ted after· the
seventh month.

However, the evidence he gives seems

to indic&te th~t the immunization of infants und~r three
months of age ~as of value, since the attack r a te in
this i::,roi.l;i was lower than in a similar non-immunized
group.

The disease in all of these infants was mild,

and he has to date recorded no death in any child who
develoJed the dise&se after injecti o n with authorized
H. p ertussis vaccine.
Sauer o.nd Tucker (62) later recommended the
givin 6 of pertuss is v&cci ne at three week intervals
after the ei 0 hth month of life, bees.use it was found
that comp leme nt-fixation tests, made two or three
months after the final injectio n, showed a higher
incidence or three &nd four plus reactions when this
procedure was followed than when the injectiqns were
given at weekly intervals, or earlier than the seventh
month of life.
The most recent work on this age q uestion has

-
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been done Ly Sako and his asso ciates (63).

over a

period of twenty-seven months they have c&rr ied out
immunization experiments f or pertussis on 3,793 infants
al~ under three months of age, the V&st majority beine
under two months of age at the time they received the
initi&l inoculation.

These infants were given alurn-

preci~itateu pertussis vaccine accordin~ tri the recommended dos&.b6 of 0 . 2, 0.3, and 0 . 5 cc ..

These in-

fants tol6rated the injections extremely well, with a
minimum of loc1;,l and systemic reactions.
The immunologic rest-lonse was measured by agglutination tests.

Tho-igh recogn ized by the author as no

absolute me~s v1.re of immunity, it is accepted as an
indication oi immunolo 6 ic res ponse.

The greatest

proportion of p ositive reactions was found between
the "thira and fourth month after completi on of the
series of inocul&tions.

The effect is apparently a

lasting one, since sixty-three per cent of the individ-

•
uals tested twenty-four months &.fter com~letion of
injections 6ave positive reactions.
The fact tru-'-t seventy-five per cent of these very
youn 6 infants exhibited antibody response as ' rneasured
by the asglutination t e st used is evidence of the
Vb..lu.e of imrnunlzation e&rly in infancy.

Sako c oncludes,

"This is contrary t..o the popul&.r belief that yoL1n 0

-
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infants ~re unable to elaborate antibodies following
active iinJJ1unization, and the question of early immQni zation against pertussis should be reopened for consideration by the profession."
Sako points to the state of Louisiana, where since
1942 more than 16,000 infants below the age of two
months, in well baby clinics, have been immunized
a 6 ainst pertussis. It is significant that mortality
figures f o r the state of Louisiana since 1942 show no
deaths reported from the immunized group .•

'l'HE

11

b00ST.Eh II INJhCTION

The term "booster" injection or dose means an
inoculation, at some time after the initial immunization,
of a sinsle dose of the same antigen for the purpose of
stimQlating a second rise in antibody titer. This
principle has not been widely ap 9lied to pertussis
immQnization. The fact is established in typhoid
im1.unization that once an individual is exposed to
an antigen his antibouy response will be markedly
amplified following subsequent exposures to the s&me
anti~}3n (64).
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Lbpin's clinical evidence (65) consisted of
twenty-three exposures in twenty-three children who
had oeen immunized with Sauer vaccine from one to five
years before exposure, six contracting whooµing cough;
twelve expo!:lll!'es in twelve children who had been
immunized with Sauer vaccine from three to six years
before exposure and who received a "stimulating" dose
of twenty billion pertussis vaccine as soon ~s possible
after· exposure, none of whom conctracted the disease.
This "stimul&.ting" dose c&used an increcJ.se in the
complement-fixation reaction, the ag~lutination reactLon,
and the mouse protection titer.
Miller and his coworkers (66), using the agglutination test, found that the titers att&ined in from two
to four months after v~ccin~tion remained constant
thereafter. With f~w exceptions, no tendency for decline
from a "plate&u" of antibody concentration ~as obs~rved
up to six ye&rs after vaccination (80 billion organisms
in one month). The question rises then as to v:hether
the a~6 lutinat~on titer is a dependable index of
immunity 1-esponse . It se e ms more logical to base opinions
of the immune response upon actual clinical evidence. --r-rt
is impossible, however, to completely disregard such
labor&tory evidence.
The report of Rambar and coworkers (67) indicates
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thc1t the p1·&ctice of "booster" dose has SO'.md scient i1 ic backing.

Their st~dies revealed that when child-

ren were ~iven

&

stimulating dose of Phase I pertussis

v1:;..ccine two ye ... rs after t h e original immuniz&tion,
"i~a~nity to whooping coubh as mebs~red by the opsonocytophai:,ic test" rose and remained &t f&irly high levels
for two and a h&lf to three years following the stimulc1.tin6 dose.
The evidence seems to indicate that the child will
get the maximum benefit of ~ctive immunization against
whoopin 6 coll 6 h when a stimulating or "booster" dose of
a;>_µroximb.tely two cc. of H. pertussis vaccine is given
&t about two hDd

b

half years of a~e.

It would be

~ell to also keep in mind the benefit of a stimulating
dose o1 abo~t two cc. of pertussis vaccine as soon as
~ossible &iter exposure, especially in those cases
where a previous "bo o ster·" dose h&d been neglected.

DETOXIFIB.D PERTUSSIS ANTIGEN

bordet (10) spoke 01 the presence of a pertussis
toxin und descril;ed patholog.y which he believed due
to ~tis toxin .

The exact part played in immunity

by tbis toxin has always remained an unknown quantity .
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In 1~3~, Evans and Maitland (68) reported on the
apparent luck of antigenicity o f this pertussis toxin
in experiments· vii th guinea pigs a.nd rabbi ts.

They

found th~t sera irorn twenty-three patients f&.iled to
neutralize the toxin.

Earlier, Miller . (69) had re p orted

•

on the lack of anti6enicity of the p ertussis toxin.
Weichsel , et al. (70 ) not only note d the same lack of
antieenicity but bro.1ght oc1t another point against
filtrates of centrifuged "toxic" broth cultures containing true exotoxins, namely, the rel&tively large
amounts necessary to kill animals.
In spite of these facts, there has been experimentb.tion with a pertussis antiben obtained from
especially antiBenic cultures of H. pertussis which
are tr an sferred to broth culture med i um to favor toxin
1Jr oduction,

centrifu6 ed and Berkfeld filtered.

The

iiltrbte is detoxiried with formaldehyde, 0.1 per
cent, for four days at 40

c .. .

The toxicity is re-

duced, but the antibenic properties are retained.

rt

has ~een called in the liter btur e "detoxified pertussis
&.nti~en".
Lapin and his group of workers reported lts results
in prophylactic use as slightly better than the use
of Sauer Vb ccine (71).

These workers also advocated

i ts use after exc=i osu.re in dosages of 0.3 to 2.0 cc. ev~ry
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two to three days, for the purpose of dGcreasing the
severity of the disease (72). Joslin and Christensen
(73) used the antigen in routine prophyl&ctic immun-

izations, as a prophylactic after exposure, and as a
ther b.peutic agent. Their res u lts were favorable in all
three fields of' use. In a carefully controlled
experiment using the antigen in treatment, Greenstein
and Levy (74) observed no apparent difference between
those receiving the antigen and uninjected (non-immunized) controls.
ore recently, Evans reported {75) that he was
able to demonstrate tht:.tt an antitoxin

W!:iS

produced upon

slow, steady &nd prolonged subcutaneous immunization
of rabbits with the "detoxified pertussis antigen".
Flosdorf, and coworkers (76) reported that their
investigations showe d the presence of a thermolabile
toxin in the antigenic solution of Evans. They found
this toxin to be weakly antigenic in rabbits but not
in human beings.
Clinic ~l work reporte d by Krb..IDer (77), and by
bullowa, et al. (78), ~ith the antigen being _given in
the incubation and catarrhal periods, upholds the
beneficial effects of its administration. Cohen, and
his ~ssociates (79), in a comparative study of therapeutic &gents in pertussis, reported that cases
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treated with this antigen seemed worse than nontreated controls.
Silverthorne and Cameron (80) confirmed the work
of Evans, and from their experiments on animals, concluded, "There is no laboratory evidence thiit

1

toxic

mt:L te1· ia.ls 1 1:1.re preferable to vaccine made from the
whole org&.nisms for use in human imrnunitation." More
recently, Silverthorne (81) wrote, "From the fact that
whooping cough is not a disease caused by

a.

toxin per

se, and from the exper· iments of others as well

a.s

from

our own obse1·v&tions, · it does not lead to the conclusion
that toxin and antitoxin products alone play any
decisive role in the prevention and treatment of
whooping cough."

.MIXED IMiilUNIZATION AND
aLUM PREC IP I'l'A'l'Eil,, PlliTUS5 IS VACCINE

An editorial (82) in the Journal of the American
Medical Association in 1937, made the following comment
on the work accomplished in France in the field of
mi xed vaccinations: "Certainly if a sound, durable
immunity c~n be de veloped in this way (and this can be
discerned by the Schick and Dick tests) the method will
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become important in prophyl&xis for its convenience and
economy." Mixed _ or combin_e d v&ccina tion involves the
simultaneous use of two or more vaccines or toxoids for
protection of the orgunism against more than one disease.
Hektoen and his students {83) showed in 1931, that
multiple antigens contained in a mixture do not impair
or diminish antibody formation. Rabbit immunization wLth
a mixture containing as many as thirty-two distinct and
separate antigens resulted in precipitin formation for
each of the individual antigens. The combination of
diphtheria toxoid and tetanus _toxoid, both alum-precipi tated, has been definitely shown (84) to result in
higher antitoxic values · against both organisms than
single prophylaxis. Ledingham, in 1939, wrote that he
was not aware that diphtheria toxoid h&d so far been
administered in combination with a pertussis vaccine,
but co 1lld see no reb.son why this should not be
attempted (85).
Ramon reported (86) that there is no such thing
as "antigenic competition" in an organism treated with
mixed vaccines, and that the several antigens introduced into an organism actually cooperate. He believed
that one of the constituents of the antibody is derived
from the c01·responding antigen, and that it confers upon
the untHJody its most essential feature, namely, its
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specificity. Only participation of an antigen or its
derivatives into the formation of the corresponding
antibody can explain the diversity of the specific
antibodibs ~hich may be formed within an individual.
shultze, 8t al. {87), in experiments on guinea
pigs and rabbits, demonstrated the compatibility of
di9htherib toxoid and pertussis vaccine, and concluded,
"In neither case does the antigenic potency of the one
suffer by tbe inclusion of the other in the inoculum!"
Simon and Crbster (88) gave a combined diphtheria and
whooping coug,h vaccine to 240 children and found satisf;;,.ctory immunizing results with both antigens. Sauer and
Tucker (62) injected pertussis vaccine and diphtheria
toxoid simultaneously in one group of children, and a
mixture of thc::se two antigens in~o a second group of
similar children. They found the immunization response,
as judged by the Schick test and the complement-fixation
test, to be equal in individual injections and in the
mixed anti 6 en. Turnbull and Varela (89) found the rabbit
better protected by a mixture of pertussis v~ccine and
alum-precipitated diphtheria toxoid than by pertussis
vaccine alone, a6ainst the intradermal injection of
live B. pertussis orbanisms.
~iller and Saito (90) concurrently immunized
against pertussis, diphtheria and tetanus. They g~ve
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seventy-six children Phase I H. pertussis vaccine and
fluid combined toxoids; one hundred children received
the pertussis v1;..ecine and &.lum-precipi,tated combined
diphtheria and tet&;.nus toxoids. In the group receiving
fluid toxoid concurrently, sixty�e1ght of seventy-tnre:e
tested had pertussis agglutinins; while in the group
receiving alum-precipitated toxoid concurrently, eighty
one of elghty�two tested h&d a�glutinins •. The findings

of Hamilton and Knouf (91), using a mixture of the
pertussis.vaccine and the fluid toxoids, were in agree
ment with Miller.and Saito. Miller, Humber, and Dowrie
(92) reported_ favorably on the use of the pertussis
vaccine and the aluminum hydroxide adsorbed toxoids,
but recommended the addition of a dose of thi-rty ol.l.Lion
H. pe-rtussis vaccine h�lf w&.y between the first and
second injections.
Lapin (93) immunized somewhat differently. He
immunized with a mixture of the foll01Jin_a antigens:
cle�r diphtheria •toxoid, alum-precipitated tetanus
toxoid, whooping cough v&.ccine, and whooping cough
toxin. The immune responses were satisfactory 1n all
cases. The whooping cough immunl�.ation resulted in
positive reactions to agglutination tests for- one
hundred per cent, complement-fixation of four plus for
eighty-seven per cent and positive for nintey-seven per
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cent, and a positive mouse protection titer for
seven per cent.
In 1938, Harrison, et al. (94) prepared an alum

precipitated pertussis vac·oine. They had reasoned that
the increased antigenic efficiency seen·when diphtheria
toxoid was precipitated oy aluminum sulfate or adsorbed
with a.L.uminum hydroxide migh_t be seen also if the
B. p6rtuss1s vaccine were precipitated with alum •
the increase in immunizing effect is probably due to
the slowness with which the precipitate is absorbed, -and
since the immunity to pertussis 1:vnot, developed, rapidly,
they reasoned that a pertussis vaccine charaet&rized Q.Y

prolonged act�on sho�ld offer greater chances for success
th"n one in which absorption and excretion takes pl
- e.c�

more rapidly. The incidence of elinicai pertussis in

the va�cinated group (12 per cent) was lower than in
the unvaccinhted group ll9 per cent), and the clinical
course run was �uch milder in the vaccinated children.
Bet� (95) wrote a follow-up for these workers in

1941, in which results with the same alum-precipitated
H. pertussis vacci�e given in twice the original dosage

.

were reported. Two doses of one cc. . with a four week
intcrv�l (total of twenty billion organisms) conferred
a real protection against clinical attacks of the
disease. Kendrick ( 96) also reported good prote_ctlon
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using an alum precipi t& ted per· tus sis vaccine.
Recently, Sako, et al. (63) reported their study
on the use of alum-precipitated pertussis vaccine in
young inf!::lnts.

over a period of twenty-seven months,

3,7~3 inf&rits under three months of age were inoculated with 0.2, 0.3, and 0.5 cc. of vaccine (forty
billion orgbnisms per cc.).

About seventy-five per

cent of these young infants exhibited antibody response
as me~sured ~y the &gglutination test.

In sixty-three

per cent the effect lasted for at least a period of
twenty-f o ,.1r months.
Kendrick (9ry~ ~se dan alum-precipitated, combined
~iphtheria toxoid and pertussis Vbccine in 1,326 preschooi children, and used a non-injected control Eroup
of l,bll c hildren .

The incidence of pertussis in the

inj8cted group was 0.9 attacks per 100 person years of
observation, in c omparison with 10.4 for the control
group.

The attacks among the v&ccinated children were ,

in 6 eneral , milder than among the controls.
Daughtry-Denm&rk (98) combined ~iphtheria and
tetan ..1s toxoids, and per tus sis vaccine, all alum-precipitated.

Good res.1lts were reported using ' a t o tal

of 2.5 cc., but it is advised that the concentr~tion
of the pertuss is vaccine be forty billion organisms
per· cc., rather than twent-y-billion.
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Lapin {99),

actin 6 on the results obtained by Daughtry-Denmark,
attempted to du.plic& te her r·esul ts, &nd succeeded.

LhbOR,i'I'ORY ME'I'HODS F'OR DETEFU IlHNG Hllvl.UN IZA'l' ION

Asiae from the v1..st number of clinic&l observat ions v,h ich have been made on the effects of immunization
by injection of H. pertussis and/or its p roducts, ther_e
hus bben an attempt to devel oi,) a laboratory method, or
methoas, for determining the immune response of each
individual.

It will be my purpose here to briefly

revie w the merits o f esch method attempted.

I might

s~y at the outs~t th&t th~ literature reve~ls many
contrbdictory results .

OPSONOCYTOPHAG IC hEAC'l'ION

Reference has been made previously to Kendrick,
Gibbs, and Sprick (46) who, in 1937, had suggested
its use as &n immune response criterion.

Lichty ,

Slavin, arid Br&df ord ( 100-) considered the reaction
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to be due to so many non-specific v&riations as to
ue valueless.
It was used more recently by Rambar, Howell, and
Goldman (101) in a well controlled study using the
o p sonocytophagic test.

They concluded that it was a

reliable index of' immunity.

Both Kendrick and her

co-workers, and Singer-Brooks and Miller (102) found
a e:,radual increbse in phagocytosis during and after
inocalation with H. pertussis vaccine, reaching a
maximum after abot1t two months.

This was followed

by a slight decline, with a high d~gree of phagocytosis
still bein 6 present after two yeurs.

AUGLuTINhiION RbACTIONS

The relationship between clinical immunity and
the &~6lt1tinin titbr in children is a much debate d
qt1es tion.

Wu &.nd Chu (103} observed agglutination

appearing after the second or third injection of vaccine, with a tendency to decline lbter .

Mishulow, et

al. (104) sho~ed a higher , lon 6 er lusting titer after
whoopine:, co.ic5h than after immunization; the protective
powbr o i

th~ ser~ms was entirely distinct from their

a 6 gl~tination pow r, the titers correspondin~ neither
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to the duration of the illness nor to the µr o tective
pow~r of the ser~ms.

Miller.and Silverberg (105)

found a higher, longer lasting titer after immunization than after an attack of whooping cough.
Lapin, et al. (71) found their ex~ erimental
resl.llts to p~rallel those of Miller and Silverberg.
This, four to ei6ht weeks after the onset of whoo o ing
cou6 h, the agglutination test b e comes positive and
remains JOsitive tor only six to twelve month s.

On

· the other hand, after· immuniz c. tion, eleven out o.f nineteen children gave p ositive agglutination tests for
three to f 1 ve ye&..rs.

North, et al. (10 6) follnd no

correl~tion uetween the Phase I aggl~tination titer
and the protective potency of

the serum.

Mish ,1low, et al. ( 107) reported the development
of protective antioodies during convalescence, and
st&tes th1;;.t they may be taken as presumptive evidence
oi immunity to pertussis .

Miller, et al. ( 66) found

no abblitination occuring in the sere of 91 of 101
children with neg&tive histories of whoopin 6 cough,
bllt demonstr a ted agglutinins in the sera of 161 of

164 children who had received H. pertussis v~ccine.
He states, "These observations suggest that whereas
immunity m1:..y exist in the absence of' demonstrable
ag~lutinins, susceptioility does not occur in the
presence of agc5lutinins in high titer."
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C0MPLhl'ilENT-1' lXAIJ.'ION REACTION

This test w&s used by severti.l writers with little
agreement in resul t s.

back in 19 25 , Madsen (24) had

noted on th e regul a rity with which the complementiixation apµetirs in whoopin€::> cough pb..tients when an
emulsion of Bordet -Ge ngo~ bacilli is .used as an antigen.
There was no reaction noted until after the first week
of the cattirrhal period.

The reaction increased grad-

ually &nd retiched its maximum during tht fifth to
seventh wE::ek period, &fter which it began to decline-the reaction persisting f or many months to a ye a r.

He

noted also that there was an increase in the comp le menti ixin~ s~bstance in pe rtussis vaccination with wh ooping
vacclne--maximum ei 0 ht days ~fter the last injection.
Lap i n (71) round the test remained positive for
only five to ei 6 bt weeks after immunization was complete.
After an att~ck of pertussis, the reaction remained
positive for less than a year in about ninety per cent
of the Cti.ses.
Dau 0 htry-Denmark (108) secured com9 lete . fixation
of complement &fter the u se o1 &dequu te amounts of
Saaer's vaccine.

Weicbse.L and Doug l &s (109) found

a decline in complement-fixation ubout three v·eeks
after the last injection of vaccine &nd very frequently
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the test was negative two weeks later.

In 1942, Lapin (110) pointed out that these
serologic tests labor under the disEdVbntage .of being
considered tests of "non-protective" antibodies •

.u40USE PROTECTION TE.S'l'S

In 1906, Miller (44) showed that mice could be
re~ularly killed with meningococci suspended in hog's
gastric mucin. Rake (111) then applied this method to
test the virulencb of strains of meningococci. Silverthorne, in 1938, recorded the results of ~njecting
str&ins of H. pertussis, suspended in gastric mucin,
intr&peritoneally, into mice (45). Ninety to one
hundred per cent of t1nvaccinated mice died. One hundred
per cent of the mice previously vaccinated with vaccines
prepared from freshly inoculated strains of H. pertussis
survived. He offered this test as a method of determining the protective v&lue of the various pertussis
VbCCines. It is interesting to note that

&

year earlier,

Toomey and Takacs {112) had failed in an attempt to
show beneficial effects with immunization in guinea pigs.
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Mishulow, et al. \104) used the intraperitoneal
method of infection of mice with H. pertussis organisms
suspended in gastric mucin, and described the test as
one readily utilizable for testing serums of patients
for protective antibodies. They found protective anti botlies in a large percentage of pertussis patients who
had been ill three weeks or longer, but only occasionally
earlier in the disease. The protective value of the
serums was apparently entirely distinct from their
a~ 6 lutinating power. Agglutinins were present in less
than a half of the serums tested, and their titers did
not cor·respond, either to the dur1:1tion of the illness,
or to the protective value of the serums. From this
evidence, one would be inclined to have more b~lief
in the mouse t'.)rotection ability of the patient's serum
than in its ag~lutinating titer.
Presumably the mouse protecting test does measure
the protective antibodies present in the serums. No
definite conclusions may as yet be drawn, as the
number of such tests recorded in the literature is
still too few to draw final conclusions. Ont-he whole,
however, the results of mouse protection tests seem to
parallel the bioloeic test of intimate exposure. There
have been various techniques described for performing
the test. In addition to the intraperitoneal method,
.....,.__,
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there h~ve been trials of intranasal instillation (106),
and of intratracheal instillation (113), (114).

The

intraperitoneal method appears to be most satisfactory.
Though the results reported have been encouraging,
there are unaccountable v&riations in the virulence of
H. pertussis which might easily m&sk the results.
Furthermore, the t e sts require a large number of animals
and some degree of proficiency of technic.

SKIN Tl!:S'l'ING

Numerous investigators have attempted to
demonstrate the reliability of an intracutaneous
test, using either pertussis vaccine or extracts of
H. pertussis as antigen or skin-testing material. There
have been conflicting reports in the literature. some
authors st ~te that there is a definite relation between
the results of cutaneous tests and immunity. Others
obtained no correlation in this regard. The type of
skin-testin 6 material used by various workers differs,
and this in turn has made their results

V&I' Y.

Siebler and Okrent (115) employed a vaccine
prepared after the method of Sauer and injected one
to two minims into the forearm, subcutaneously. Readings
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~ere taken in seventy-two hours. A negative test
indicated immunity; a positive test, susceptibility.
Eighty per cent of persons tested who had not had
pertussis according to ,the history gave

b

positive

reaction; whereas, seventy-six per cent who had had
th~ disease did not rebct. Also a group of twenty-five
children who had been skin positive and were then
immunized, became skin negative when later tested.
The investi 6 ations of Thompson (116) did not
support the claims of sauer's vaccine used in skin
testing, but found the intradermal response to pertussis
' endotoxin, on the other hand, to be much more satisfactory. He reported a bacterial hypersensitiveness, as
judged by the pertussis endotoxin test, which appears
about the tenth day of whooping cough u.nd becomes
heightened durin 5 the subsequent course of the disease.
The regression of this hypersensitivity is not complete
and, therefore, he believed, this pertussis endotoxin
test should be of value in assessing the immune state .
strean (117}, using the endotoxin, believed the
test to bear the same relationship to whoopin~ cough
as the Schick test does to diphtheria. But it has never
been shown that whooping cough is in the no.ture of a
"toxin-antitoxin" disea s e. He found positive skin tests
in ala.er children and adults surprisingly high.
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This

he attributed to poor immunity, bu~ it seems possible
that his testing could have been at fault. Weichsel,
et al. (70) reported disappointing results using the
toxin as a skin testing reagent.
Flosdorf, Bondi, and Dozois (76), and Flosdorf
and McGuiness (118) pointed out that conflicting
observations had been made previously, primarily
because reagents used had contained both agglutinogen
and toxin .

The former causes a reaction in persons

who are immune, and the latter in persons who are
susceptible . By sep~ration of the cellular components,
subst~nces responsible for these various reactions may
-oe distinguished. They raise the question, "How much
promise of success c&n be expected from the use of' a
toxin as reagent in a dermal test, when the disease
does not have dermal toxicity as a symptom and is not
liSsoci&ted with th~ formation of anti-toxin during the
course of' the disease, or during active immunization?"
However, a year previo~s, strean, Lapointe, and Dechene
(119) had found close correlation between immunity and
the use of the p ~rtussis toxin &s a skin-te s ting
rnatE-rial.
Flosdorf, et al. (120) reported a skin test
utilizing purified pertussis agglutinogen as the
rea~ent, declaring that it classifies immune and
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susceptibl~ individuals in accord with their history
of incidence of infection and vaccin~tion with H. pertussis. On the basis of the ag~lutination test titers,
they claimed &lso that the test stimul&ted immunity.
They stressed the value of the reagent, therefore, in
~imes of epidemic. This purified agglutinogen as a
testin6 reagent was vigorously sup ~orted by Smolens and
Mudd ( 121).

The satisfactory skin test has not yet been devised.
However, it appear·s th&. t Flo sdorf and her coworkers &.re
nearing the correct answer by separating the v&rious
cell.ul&I' components of the H. pertussis organism. The
sep1::;..ration of immune &nd non-immune individuals by the
use of' a skin test using the agglutinogen (purified)
appears to be the most successful s.ttempt reported
thus far.
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COr VALI:!.SCE. ijT AND HYP:B.fiI1vlro.UNh SIBUlVl

½hoopin 6 cough vaccination is usually not begun
until tbe infant's sixth or seventh month of life.
Protection from the vaccinbtioL is not dBveloped until
sqme time later.

This leaves the infant unprotected

d.1rin6 the period of life when whooping cough is most
likely to L;e f&ta.l.

It should be remembered that the

inf~nt derives no protection agLJinst whooping cough
from his mother.

A development ln scrotherapy by

which p1,.ssi ve immunity is gl ven these inf ants v11 hen
proteciion is essential has · een tried.

I shyll briefly

sketch the im~ortant points of this development .
'I'he use of' conv1;,.lescent serum to control and
p1·event whoo pin~ cough was reported as etirly as 1~01
( 12~).

Gr9ham noted in 1912 th&t the serum of indivici,1als

who have never had whoopin6 cough, o~ who had had it~
lon 6 time before, does not agglutinate the H. bacillus
even in low dilution.

On the other hb.nd, "the ser ·1m of

childrt=n who h1:i.ve recently recovered from the disease
h::..s a ,i1oder::.te ae,gl.1tinatin6 property" (14) • .
In 1917, Bleyer (120) carried on a clinical
experiment in which he injected blood from persons
convalesct:mt from whoo_pin 0 cough into children who
had the: disease .

'I'he dose of blood was from a tenth

-

5.U -

to a. fifth oi the body wei 6 ht.

He found the course

of the disease w&s in no definite way dif f erent from
th~t usually se ~n.
In 19 ~~. Jundell {124) reported the use of blood
taken from adults who haa received freshly prepared H.
pertussis vaccine within a few days prior to the withdr.&wl oi the blood.

ALL of these donors were known

to ba.ve had the disease previously.

On the basis of

comparison with observ~tions on controls, a definitely
favorable effect was produced by the use of t~e blood.
Bradford (125) collected convales0ent serum from
youne, adults in the ei 6 hth week of the disease and preserved it in ten cc. vial s by the addition of 0.25 per
ctnt cresol.

The serums were not pooled and were kept

in the ice uox.

It was injected in from eight to ten

cc. doses, intramusc~larly.

Whole blood was also taken

from one or the othel' of the chi.1.d's parents, who had bad
whoopin6 cou~h during childhood, and was injected in
from ten to t wenty cc. amounts, intr~muscularly.
He saw protective qualities against whooping cough
when elthbr the conv ~lescent serum or the whole
blood was elven aftor exposure but before the catarrhal
symptoms ap _-1eared; the attack rb.te was decreased and
the clinic&..l cours e was milder.
that neither

0 reatly

However, he emphasized

influences the course of the disease
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if given after the cat ~rrhal stage is established.
Metider (126) pointed out that the use of convalescent ser i.un in whoo;iing cough differs somewhat
from its use in scarlet fever due to the longer incuoation period in whooping cou 6 h.

The incubation

period is so lon~ that while one of two children in
a given f&mily, receiving serum prophylactically at
a fortuitous moment, will be protected, another will
contract whoopin 0 cou 6 h in the latter part of the
incubation period.

He believed that if given by a.

physicia1 , who undE;;rs tsna s its precise use, a considbrable reward will be obt&ined.

A

larger dos& 6 e

~as advised, and he reports a protection of seventyfive per c ent of children who would have other~ise
acquired ~he disease.
Toomey (43) found th&t serums ootained from
rabbits, sheep and horses injected with Phase I organislfis to the µoint where the agblutinin titer s of the
vari 0 us blood serums reached a point as hic,h as 1:40,000
did not moaify or prevent the clinical dise1;:,.se fr om
occurin6 in human beings.

In fact,

condition was actually made worse.

the clinicul
Lapin (li0)

explained these ~oor results by show_ng thut these
sera of bnim~ls lacked antisk in-necrotizin 6 immune
body cont1;:,.ined in hum!:l.n sera.
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Ir- g e neral, serologic

\,,,...--

tests such as agglutination titeI's seem to run parallel
to ~rotective antibodies in pertussis; yet animal sera
may have high agglutination titers with practically
no antiskin-necrotizing immune body.

However, Bradford,

et al. (12'7) found sixty-five per cent protection in
infants after the prophylactic use of concentrated
antiserum from rabbits immunized with living h. pertuasis
organisms.

The effect seemed anti-tacterial and not

anti toxic.
Cohen and Lapin ,128) studied the use of various
prophylactic mea.surts in exposed cases of whoopin 6
co.1 6 h.

Ad 1l t blood serum was effective in sixty-one
1

p~r cent oi children intimately exposed, and the course
of the disease in those who contracted it was
modified.

6 enerally

The doses recommended were twenty cc. for

inf&nts and forty cc. for older children.

They ob-

taine d hyperimmune serum from inq.ividuals with a
history of whoopin 6 cough inoculating them

·ith large

dos~s of H. pertussis vaccine ( 2 0 cc.) over a period
of six to ei 0 ht weeks.
or two weeks later.

Their serum was obtained one

such serum protected sixty-six .

per cent of their cases and modified the couise of
rest.

l1e

They found convalescent serum the most effective

prophylactic agent, and advised fifteen to twenty cc.
for an inf ant and forty cc. for an older child.

-
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Nortr. et al . (106) used the reduction of mortality
in mice biven lethal doses of H. pertussis (Phase I)
intranasally as the criterion of tht protective power
of serum e:;iven intrapE:ritoneally in amounts of 0.25
to 0.30 cc. four hours bef ore the infectinB dose.

A

protective antibody was shown to be present in the serum
of children convalescent from whoop inc, cougt, of children immunizE-d with H. pertussis, of some adults who
had come in contact with patients with pertussis,
and oi rabbits immunized

with living cultures of H.

pertussis, both virulent (Phase I) and avirulent (Phase
III) strains.

It was not detectible in pooled serum

of healthy adults or in the serum of children who had
not been immunized.

North &nd Anderson (129) reported

lt:tter tht...t pooled normal human serum contai n s protective
antibodies age.inst H. pertussis infection in mice
and su6~ested that such serum might be of value as
a prophylactic in youn 5 non-imn1unize d children exp osed
to infection.
In l'.:1c7, McGuinness, stokes and Mudd {"130) ma.de
a pr·eliminary report on the use of' pooled human serl.lID
pre:,jerved by the "lyophile" method .

The pooled serJ.ms

were preserved by drying, in vacuo, from the frozen
state; the dry porous material resulting was called
"lyophilerr serum, &nd could be redissolved in as little
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as one fourth of its original volume of liquid.

The

pooled serum was obtained by giving healthy ~d ults
several full courses of injections of Sauer's vaccine
biving one full course of vaccine every four months.
The dono1s were bled at varying intervals and the
serum separ&ted and processed uy the lyophile method.
This study v1as continuea and they reported { 131)
three years l&ter th~t most of the donors had been
b~ed at approxim~tely one-to-two month intervals
following the initial bleeding, and have continued
to receive eight cc. courses of Sauer vaccine at
four to six month i ntervals.

This latter was in

accordance with the established fbct in typhoid immunization th~t once an individual is ex posed to an
anti 6 en, his antibody respon s e will be markedly amplified following subse quent exposures to the same
b.n ti 6 en.
The resulting hyperirnune serum was used both in
prophy.Laxis and in treatment of whoopin~ cough.

Of

ei 6 hty-three non-immunized children exposed to whooping cough and receiving the hyperimmune serum, intramuscJlbrly, Defore the onset of ca~arrhal syiptoms,
eighteen {:::;1.7 per cent) developed the d iseb.se.

Of

these eighteen children, only seven had whooping and
vomitin~.

Most of these children received two injections
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\,,,../

of' serum from five to seven days apart.

The second

injections were given because of the relatively long
incubation period of whooping cou~h end the fact that
passive immunity may last for ten to fourteen d&.ys
only.
To test the effectiveness of the hyperimmune
serum in treatment, one hundred children with whooping cough, fifty-one being six months of a 0 e or
younger, were given, in general, twenty cc. of the
serum, intramuscularly, every other day until three
doses had been given.

There were excellent results

in thirty-two cases, moderate results in thirty-one
C8ses, and questionable results in fourteen cases.
The best results were seen in the younger infants and,
in all cases, when ther·apy was begun in the first two
weeks of the disease.
scheinulum and Bullowa (132) found very good
response to tre&tment with the hyperimmune serum in
seventy-five per cent of infants under three months of
age.

They su~bested th&.t the better response in the

younger infants might be due to the fact that the age
and weight of the patients were not considered in the
dosa6e 6 iven.

Frank, Patton, and Hamilton (133)

used the hyperimrnune serum in thirty consecutive
cases of whooping cough bronchopneumonia and were
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convinced that the serum had a placB as supportive
measure but that it is not a specific cure.
McGuinness, et al. (134) attacked the results of
Hamilton and his group on the basis of insufficient
dosa 6 e. They bad given but two and a half to three
cc. of the serum per pound body weight on admission.
On this basis, a six month old infant weighing fifteen
pounds would receive a maxi~um therapeutic dose of
forty-five cc. of serum, even though seriously ill with
bronchopneumonia. McGuinness· points out that in cases
of a critically ill infant, from 100 to 200 cc. of
serum (intravenously) m·ay be required. It is felt that
a rninimum treatment should be three twenty cc. injectiuns
of serum at forty-eight hour intervals reg&.rdless of
age, and making a total of sixty cc •• Under their stud y,
poor results in treatment of cases with the serums were
less thi:in ten per cet1t.

Their work in prophylactic

use of the serum closely parblllels earlier reports,
78.6 per cent of 308 exposed non-immune children
failed to contract the disease.
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CONCLUSION

In this paper, an attempt has been made to
review a n d organize the work which has been done on the
immunity and serologic aspects of the disease, whooping
cough.

From the literature covered and analyzed in

developing the several phases of the subject, I believe
it is possible to draw the following conclusions:
(1) Pertussis is a disease which has highest mortality
in infants and young children.
(2) Since therapeutic measures in pertussis management
have always been inadequate, it is desirable to prevent
the disease from occuring.
(3) Active immunization against pertussis by the use
of a Sauer type vaccine, in adequate dosage, has proved
to be hi 6 hly successful.
(4) There is no conclusive evidence available which
proves that any other immunizing material is more
beneficial in pertussis prophylaxis than the whole
H. pertussis organism, in Phase I, as used in the
Sauer type vaccine.
(5) The immunization of infants as early as one or
two months after birth seems to be desirable and logical.
Thou~h protection resulting from immuniz&tion at this
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early age is not as complete as when the vaccination
takes place at six or seven months of age, the course
of the dise&.se, if acquired after immunization, is
reported to be much less severe.
(6) A "booster" injection of about two cc. of the Sauer
type vaccine around two &nd a half years of age increases
the immunity of the child and should be included in the
routine immunization progr&m.
{7) The alum-precipitated H. pertussis vaccines have
proved to be more effective, in much smaller doses, than
the authorized fluid Sauer typ~ v&ccine.
(8) There are no reasons found in the literature for
not giving pertussis vaccine, combined with diphtheria
and tetanus toxoids. All three may be given in the alumprecipitated form, in order to decrease both the volume
of the injected material &.nd the total number of injec_tions necessary.
(~) There is as yet no laboratory method which is
absolute in determining those individuals immune and
non-immune to pertussis. Of the several methods used,
the mouse protection test ap pe~rs to be the most accurate
at present. However, the experimentation being done
upon skin-testing for pertussis may soon result in a
much more simple procedure.
(10) \\hen infants &.nd young _children are exposed to
_......,,

-
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whooping cou~h, or if they acquire the disease, it is
desirable to bestow some degree of passive immunity
upon them by the injection of large doses of byperimmune serum. This has proved to decre&se both the
morbidity and mortality.
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